Stocks · Health care · Biological Products, (No Diagnostic Substances)

4D Molecular Therapeutics, Inc.

FDMT Clue Score62
United States Fiscal year ends December CIK 0001650648 Results filed 13 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Viking Global Investors LP
9 May 2023
10% owner
Buy indirect
850,000
$16.00
$13.60M
Tony Dung Ling Yao
15 Dec 2020
Director
Buy indirect
425,000
$23.00
$9.78M
Fariborz Kamal
15 Dec 2020
See Remarks
Buy
4,347
$23.00
$99.98K
John F Milligan
15 Dec 2020
Director
Buy indirect
100,000
$23.00
$2.30M
Viking Global Investors LP
15 Dec 2020
10% owner
Buy indirect
1,100,000
$23.00
$25.30M

What was left out

Form 4 filings counted 142
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 5
Sales on a Rule 10b5-1 plan 18
Sales straight out of an exercise 54
Sales at will 24
Transactions with no price 0
Shares from compensation/vesting 11,101,263
Sales filed before the plan box existed 22
History held since 17 Dec 2020